Transgene and NEC Present First Clinical Benefits of Neoantigen Cancer Vaccine, TG4050, in Head & Neck Cancer at AACR 2024
Source Node: 2541233
Time Stamp: Apr 10, 2024
euronext
Exclusive Networks: Availability of Its 2023 Universal Registration Document, Annual General Shareholders’ Meeting of June 6, 2024
Source Node: 2536806
Time Stamp: Apr 5, 2024
Strong data from DSR® proof-of-concept studies in heart failure published in European Journal of Heart Failure | BioSpace
Source Node: 2533777
Time Stamp: Apr 2, 2024
Trading carbon, trading up: the public companies transforming sustainability
Source Node: 2534935
Time Stamp: Mar 28, 2024
ONWARD® Medical Accepted to New US FDA TAP Program for Development of its ARC-BCI™ System | BioSpace
Source Node: 2511069
Time Stamp: Mar 10, 2024
Transgene, NEC, and BostonGene Expand Collaboration for Phase I/II Clinical Trial of Neoantigen Cancer Vaccine TG4050
Source Node: 2504189
Time Stamp: Mar 4, 2024
Strong data from DSR® proof-of-concept studies in heart failure accepted for late-breaking presentation at THT 2024 | BioSpace
Source Node: 2498273
Time Stamp: Feb 27, 2024
Our journey to a greener future: DGB Group’s strategic expansion into the French market
Source Node: 2491155
Time Stamp: Feb 22, 2024
Flutter Entertainment Expands Partnership With PARI MUTUEL URBAIN; Strengthens Presence In UK Market With BetConstruct
Source Node: 2489276
Time Stamp: Feb 20, 2024
Nukkleus to Acquire Mercury Global to Enhance Cross-Border Payments
Source Node: 2480635
Time Stamp: Feb 14, 2024
Flutter Entertainment Delists from Euronext Dublin Prior To US Listing
Source Node: 2454612
Time Stamp: Jan 24, 2024
AFYREN Announces Its Financial Calendarfor Fiscal Year 2024
Source Node: 2440189
Time Stamp: Jan 13, 2024
Transgene and NEC Extend their Collaboration to Continue Joint Clinical Development of Neoantigen Cancer Vaccine TG4050
Source Node: 2434630
Time Stamp: Jan 9, 2024
Sequana Medical granted US CPT® III reimbursement codes for alfapump® system | BioSpace
Source Node: 2425820
Time Stamp: Jan 2, 2024
Sequana Medical submits Premarket Approval application to US FDA for alfapump® in recurrent or refractory ascites due to liver cirrhosis | BioSpace
Source Node: 2417283
Time Stamp: Dec 27, 2023
Median Technologies to Speak at the Radiological Society of North America 2023 Annual Meeting, Nov. 26 – 30, Chicago, IL, USA
Source Node: 2395577
Time Stamp: Nov 22, 2023
Pixium Vision announces the 48-Month Trial Results in Severe Atrophic AMD | BioSpace
Source Node: 2382127
Time Stamp: Nov 13, 2023
Medidata Announces New Data Integration Solutions to Accelerate Clinical Trials: Clinical Data Studio and Health Record Connect
Source Node: 2374611
Time Stamp: Nov 8, 2023